Preferred Label : Vildagliptin;

MeSH definition : A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.;

MeSH synonym : (2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile;

MeSH hyponym : NVP LAF237;

Wikipedia link : https://en.wikipedia.org/wiki/Vildagliptin;

UNII : I6B4B2U96P;

Details


Main resources

You can consult :

A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.

https://www.ema.europa.eu/en/medicines/human/EPAR/vildagliptin-metformin-hydrochloride-accord
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Vildagliptin
Vildagliptin
drug combinations
Metformin Hydrochloride
Metformin Hydrochloride
metformin and vildagliptin
drugs, generic

---
https://www.has-sante.fr/jcms/p_3284684/fr/eucreas-50-mg/1000-mg-vildagliptine-/-metformine
2021
false
false
false
France
hypoglycemic agents
Metformin Hydrochloride
drug combinations
Vildagliptin
dipeptidyl-peptidase iv inhibitors
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
evaluation of the transparency committee
metformin
administration, oral
treatment outcome

---
https://www.has-sante.fr/jcms/p_3283467/fr/galvus-50-mg-vildagliptine
2021
false
false
false
France
evaluation of the transparency committee
Vildagliptin
dipeptidyl-peptidase iv inhibitors
treatment outcome
insurance, health, reimbursement
administration, oral
diabetes mellitus, type 2
vildagliptin
drug therapy, combination

---
https://www.has-sante.fr/jcms/p_3224069/fr/eucreas
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
drug combinations
administration, oral
Vildagliptin
Metformin Hydrochloride
metformin and vildagliptin
diabetes mellitus, type 2
hypoglycemic agents
metformin

---
https://www.cadth.ca/sites/default/files/pdf/E0007_vildagliptin_edrug_f.pdf
Canada
French
hypoglycemic agents
diabetes mellitus, type 2
drug evaluation
clinical trials as topic
hypoglycemic agents
adamantane
vildagliptin
drug evaluation
Product containing glucagon-like peptide 1 receptor agonist (product)
Substance with glucagon-like peptide 1 receptor agonist mechanism of action (substance)
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_2038277/fr/galvus-jalra
http://www.has-sante.fr/portail/jcms/c_1778236/fr/galvus-/-jalra
2015
false
France
French
hypoglycemic agents
drug therapy, combination
insulin
metformin
Sulfonylurea Antidiabetic Agent
sulfonylurea compounds
treatment outcome
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
diabetes mellitus, type 2
vildagliptin
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_2038125/fr/eucreas-icandra
2015
true
France
French
sulfonylurea compounds
drug therapy, combination
insulin
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1778230/fr/eucreas-/-icandra
http://www.has-sante.fr/portail/jcms/c_1778230/fr/eucreas/icandra-vildagliptine/metformine-antidiabetiques
2014
true
France
French
drug therapy, combination
insulin
guidelines for drug use
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1774632/fr/galvus-/-jalra
http://www.has-sante.fr/portail/jcms/c_1774632/fr/galvus/jalra-vildagliptine
2014
false
France
French
sulfonylurea compounds
hypoglycemic agents
drug therapy, combination
guidelines for drug use
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
diabetes mellitus, type 2
vildagliptin
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1762678/fr/eucreas
2014
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1778245/fr/eucreas-/-icandra
2014
true
France
French
sulfonylurea compounds
drug therapy, combination
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/icandra-previously-vildagliptin-metformin-hydrochloride-novartis
2012
false
United Kingdom
French
English
syndication feed
metformin
hypoglycemic agents
adamantane
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
drug combinations
dipeptidyl-peptidase iv inhibitors
drug approval
drug labeling
treatment outcome
metformin
hypoglycemic agents
tablets
administration, oral
diabetes mellitus, type 2
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
metformin and vildagliptin
drug evaluation
summary of product characteristics
package leaflet
drug therapy, combination
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Jalra
2012
United Kingdom
French
English
syndication feed
adult
treatment outcome
drug approval
drug labeling
diabetes mellitus, type 2
hypoglycemic agents
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyrrolidines
adamantane
nitriles
dipeptidyl-peptidase iv inhibitors
tablets
administration, oral
drug therapy, combination
dipeptidyl-peptidase iv inhibitors
vildagliptin
package leaflet
summary of product characteristics
drug evaluation
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Xiliarx
2012
United Kingdom
French
English
syndication feed
adamantane
nitriles
dipeptidyl-peptidase iv inhibitors
tablets
pyrrolidines
dipeptidyl-peptidase iv inhibitors
administration, oral
drug approval
drug labeling
treatment outcome
drug therapy, combination
diabetes mellitus, type 2
adult
hypoglycemic agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
vildagliptin
package leaflet
summary of product characteristics
drug evaluation
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Zomarist
2012
United Kingdom
English
French
syndication feed
pyrrolidines
adamantane
nitriles
dipeptidyl-peptidase iv inhibitors
drug combinations
metformin
metformin
dipeptidyl-peptidase iv inhibitors
tablets
administration, oral
diabetes mellitus, type 2
hypoglycemic agents
hypoglycemic agents
treatment outcome
drug approval
drug labeling
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
metformin and vildagliptin
package leaflet
summary of product characteristics
drug evaluation
drug therapy, combination
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Eucreas
2012
United Kingdom
English
French
syndication feed
hypoglycemic agents
pregnancy
nitriles
pyrrolidines
metformin
administration, oral
drug evaluation
treatment outcome
adult
aged
drug interactions
nitriles
pyrrolidines
metformin
drug evaluation, preclinical
drug approval
drug labeling
adamantane
drug combinations
diabetes mellitus, type 2
metformin and vildagliptin
breast feeding
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
drug evaluation
summary of product characteristics
package leaflet
drug therapy, combination
Vildagliptin
Vildagliptin

---
https://www.ema.europa.eu/medicines/human/EPAR/Galvus
2012
United Kingdom
English
French
syndication feed
administration, oral
adult
pyrrolidines
nitriles
adamantane
pyrrolidines
hypoglycemic agents
nitriles
adamantane
hypoglycemic agents
treatment outcome
drug evaluation, preclinical
drug approval
drug labeling
pregnancy
breast feeding
drug interactions
diabetes mellitus, type 2
aged
vildagliptin
drug therapy, combination
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
package leaflet
drug evaluation
summary of product characteristics
Vildagliptin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68382713
2012
France
summary of product characteristics
package leaflet
tablets
metformin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65787998
2012
France
summary of product characteristics
package leaflet
tablets
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62091971
2012
France
summary of product characteristics
package leaflet
tablets
metformin
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1362324/galvus-vildagliptine-inhibiteur-de-la-dipeptidylpeptidase-4
http://www.has-sante.fr/portail/jcms/c_1362323/galvus-synthese-21112012-ct12484
2012
France
French
vildagliptin
administration, oral
dipeptidyl-peptidase iv inhibitors
diabetes mellitus, type 2
guidelines for drug use
product surveillance, postmarketing
dipeptidyl-peptidase iv inhibitors
treatment outcome
randomized controlled trials as topic
insurance, health, reimbursement
nitriles
nitriles
pyrrolidines
pyrrolidines
adamantane
Vildagliptin
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67520378
2012
France
summary of product characteristics
package leaflet
tablets
Vildagliptin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60892792
2012
France
summary of product characteristics
package leaflet
tablets
metformin
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1343141/galvus
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-12/galvus_ei_monotherapie_avis2_ct12484.pdf
http://www.has-sante.fr/portail/jcms/c_749355/galvus
2012
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
diabetes mellitus, type 2
vildagliptin
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
nitriles
nitriles
pyrrolidines
pyrrolidines
adamantane
Vildagliptin
Vildagliptin

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/jalra_-_ct9789.pdf
http://www.has-sante.fr/portail/jcms/c_1098672/jalra
2011
France
French
evaluation of the transparency committee
guidelines for drug use
nitriles
nitriles
pyrrolidines
pyrrolidines
adamantane
administration, oral
dipeptidyl-peptidase iv inhibitors
vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
drug therapy, combination
adult
aged
continuity of patient care
treatment outcome
risk assessment
dipeptidyl-peptidase iv inhibitors
Vildagliptin
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_1098669/icandra
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/icandra_-_ct9790.pdf
2011
France
French
evaluation of the transparency committee
nitriles
nitriles
pyrrolidines
pyrrolidines
adamantane
drug combinations
administration, oral
metformin
dipeptidyl-peptidase iv inhibitors
metformin and vildagliptin
hypoglycemic agents
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
continuity of patient care
treatment outcome
hypoglycemic agents
metformin
dipeptidyl-peptidase iv inhibitors
Vildagliptin
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_798093/eucreas
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-05/eucreas_-_ct-5439.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/eucreas_ct_5439.pdf
2009
France
English
French
evaluation of the transparency committee
drug combinations
administration, oral
metformin
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
nitriles
pyrrolidines
adamantane
metformin and vildagliptin
insurance, health, reimbursement
diabetes mellitus, type 2
adult
aged
treatment outcome
Vildagliptin

---
http://www.has-sante.fr/portail/jcms/c_841933/eucreas-vildagliptine-/-metformine-antidiabetique-oral
http://www.has-sante.fr/portail/jcms/c_799890/eucreas-ct-5439
2006
France
French
nitriles
pyrrolidines
adamantane
hypoglycemic agents
metformin
diabetes mellitus, type 2
drug combinations
adult
administration, oral
dipeptidyl-peptidase iv inhibitors
treatment outcome
therapeutic equivalency
metformin and vildagliptin
guidelines for drug use
evaluation of the transparency committee
Vildagliptin

---
Nous contacter.
06/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.